A complete application in a minute — tailored resume and cover letter, ready to send.
GSK is seeking an ACCA Trainee to join the Site Finance team in Karachi. You will support month-end close, reporting and accounting tasks, collaborating with finance colleagues across sites and business partners. This role offers strong development for the ACCA journey in a global biopharma context.
You will gain exposure to IFRS and internal controls while contributing to plans, budgets and process improvements, with a focus on accuracy and learning.
You will join our Site Finance team as an ACCA Trainee. You will support financial analysis, reporting, month-end close and accounting tasks. You will work closely with finance colleagues across sites and with business partners. We value curiosity, attention to detail and a drive to learn. This role gives you meaningful exposure to finance in a global company and strong development for your ACCA journey. Join us to apply your skills, grow quickly, and help us unite science, technology and talent to get ahead of disease together.
You will join our Site Finance team as an ACCA Trainee. You will support financial analysis, reporting, month-end close and accounting tasks. You will work closely with finance colleagues across sites and with business partners. We value curiosity, attention to detail and a drive to learn. This role gives you meaningful exposure to finance in a global company and strong development for your ACCA journey. Join us to apply your skills, grow quickly, and help us unite science, technology and talent to get ahead of disease together.
Business Reporting Tools, Data Storytelling, Digital Fluency, Financial Modeling, Financial Performance Improvement, Influencing Without Authority, Insight Generation, Problem Solving
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.